VK
Vijaya Kumar Hamsa
About Vijaya Kumar Hamsa
Data last updated:
Vijaya Kumar Hamsa is a Director at Innovative Pharma Solutions Private Limited (since 2025) and Director at V3s Life Sciences Private Limited (since 2023). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹3.03 Cr; the largest is Innovative Pharma Solutions Private Limited at ₹2.63 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Feb 2025 | 2019 | ₹2.63 Cr (FY 2024) | Active | |
| Director | 23 Mar 2023 | 2023 | ₹40.2 Lakh (FY 2024) | Active |
Board colleagues of Vijaya Kumar Hamsa
| Name | DIN | Company | Designation |
|---|---|---|---|
| Hamsa Sandhya Rani | 10085721 | Innovative Pharma Solutions Private Limited , V3s Life Sciences Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vijaya Kumar Hamsa
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vijaya Kumar Hamsa
Vijaya Kumar Hamsa currently holds 2 directorships: Innovative Pharma Solutions Private Limited (Director, since 15 Feb 2025, revenue ₹2.63 Cr (FY 2024)); V3s Life Sciences Private Limited (Director, since 23 Mar 2023, revenue ₹40.2 Lakh (FY 2024)).
Vijaya Kumar Hamsa was first appointed on 23 Mar 2023 as Director at V3s Life Sciences Private Limited. The most recent appointment on record is 15 Feb 2025 at Innovative Pharma Solutions Private Limited.
The 2 current companies of Vijaya Kumar Hamsa that report revenue have a combined latest revenue of ₹3.03 Cr: Innovative Pharma Solutions Private Limited ₹2.63 Cr (FY 2024); V3s Life Sciences Private Limited ₹40.2 Lakh (FY 2024).
The current boards of Vijaya Kumar Hamsa's companies include Hamsa Sandhya Rani (Innovative Pharma Solutions Private Limited).